• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[II型糖尿病患者药物治疗支持的问题]

[The problems of pharmaceutical support of patients with diabetes mellitus type II].

作者信息

Khabriev R U, Malichenko V S, Malichenko S B

出版信息

Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med. 2016 Jul-Aug;24(4):196-200.

PMID:29557591
Abstract

The diabetes mellitus acquires a character of sheer spreading global epidemic. Nowadays, in the Russian Federation number of patients with diabetes mellitus reaches 10 million. The accessibility of pharmaceuticals is one of main elements of support of effective treatment of disease. The analysis of federal and regional normative legal acts, territorial programs of state guarantees and data of portal of state purchases demonstrated inefficiency of actual regional system of medicinal support especially in modern economic situation. The necessity of optimization of state costs and also broadening of medicinal coverage of population, including pharmaceuticals for treatment of diabetes mellitus type II, requires development and implementation of step-by-step plan of reforming of regional system of preferential medicinal support.

摘要

糖尿病已成为一种全球范围内急剧蔓延的流行病。如今,在俄罗斯联邦,糖尿病患者人数已达1000万。药品的可及性是支持疾病有效治疗的主要因素之一。对联邦和地区规范性法律文件、国家保障领域计划以及国家采购门户网站数据的分析表明,现行的地区医疗保障体系效率低下,尤其是在当前的经济形势下。鉴于优化国家成本以及扩大民众药物覆盖范围(包括用于治疗II型糖尿病的药物)的必要性,需要制定并实施地区特惠医疗保障体系改革的分步计划。

相似文献

1
[The problems of pharmaceutical support of patients with diabetes mellitus type II].[II型糖尿病患者药物治疗支持的问题]
Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med. 2016 Jul-Aug;24(4):196-200.
2
Fighting trafficking of falsified and substandard medicinal products in Russia.打击俄罗斯假药和劣药的非法交易。
Int J Risk Saf Med. 2015;27 Suppl 1:S37-40. doi: 10.3233/JRS-150681.
3
[Diabetes mellitus type 2: National Russian guidelines vs real clinical practice].
Ter Arkh. 2023 Nov 23;95(10):833-838. doi: 10.26442/00403660.2023.10.202424.
4
[Diabetes mellitus in the Russian Federation: Arguments and facts].[俄罗斯联邦的糖尿病:论据与事实]
Ter Arkh. 2016;88(10):4-8. doi: 10.17116/terarkh201688104-8.
5
[Modeling of normative and legal acts within the health care system].[医疗保健系统内规范性和法律行为的建模]
Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med. 2003 May-Jun(3):4-7.
6
[Impact of antidiabetic therapy on the risk of cardiovascular diseases and their complications in patients with type 2 diabetes mellitus].[抗糖尿病治疗对2型糖尿病患者心血管疾病及其并发症风险的影响]
Ter Arkh. 2010;82(8):71-5.
7
Diabetes prescribing rises by a third over five years.
BMJ. 2016 Oct 10;355:i5484. doi: 10.1136/bmj.i5484.
8
[The actual Russian legislation in sphere of turn-over of drug agents and psychotropic substances].[俄罗斯在药品和精神药物流通领域的实际立法]
Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med. 2014 Mar-Apr(2):9-14.
9
The cost-effectiveness analysis of JinQi Jiangtang tablets for the treatment on prediabetes: a randomized, double-blind, placebo-controlled, multicenter design.金芪降糖片治疗糖尿病前期的成本效益分析:一项随机、双盲、安慰剂对照、多中心设计研究。
Trials. 2015 Nov 3;16:496. doi: 10.1186/s13063-015-0990-9.
10
[The issues of legal support of municipal public health].[城市公共卫生的法律支持问题]
Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med. 2011 Jan-Feb(1):21-3.